HK1209348A1 - Use of bacteroides thetaiotaomicron in the treatment or prevention of rheumatoid arthritis or related diseases - Google Patents
Use of bacteroides thetaiotaomicron in the treatment or prevention of rheumatoid arthritis or related diseasesInfo
- Publication number
- HK1209348A1 HK1209348A1 HK15110140.1A HK15110140A HK1209348A1 HK 1209348 A1 HK1209348 A1 HK 1209348A1 HK 15110140 A HK15110140 A HK 15110140A HK 1209348 A1 HK1209348 A1 HK 1209348A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- prevention
- treatment
- rheumatoid arthritis
- related diseases
- bacteroides thetaiotaomicron
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410522420.6A CN104546935A (en) | 2014-09-30 | 2014-09-30 | Application of bacteroides thetaiotaomicron in treating or preventing rheumatoid arthritis or related diseases thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1209348A1 true HK1209348A1 (en) | 2016-04-01 |
Family
ID=53064707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15110140.1A HK1209348A1 (en) | 2014-09-30 | 2015-10-15 | Use of bacteroides thetaiotaomicron in the treatment or prevention of rheumatoid arthritis or related diseases |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN104546935A (en) |
HK (1) | HK1209348A1 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
SI3193901T1 (en) | 2014-12-23 | 2018-06-29 | 4D Pharma Research Limited | Pirin polypeptide and immune modulation |
LT3065748T (en) | 2014-12-23 | 2018-03-12 | 4D Pharma Research Limited | A bacteroides thetaiotaomicron strain and its use in reducing inflammation |
MA41060B1 (en) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
MA51639A (en) | 2015-06-15 | 2020-04-15 | 4D Pharma Res Ltd | COMPOSITIONS CONTAINING BACTERIAL STRAINS |
DK3307288T3 (en) | 2015-06-15 | 2019-10-07 | 4D Pharma Res Ltd | COMPOSITIONS COMPREHENSIVE BAKERY STUES |
PE20180242A1 (en) | 2015-06-15 | 2018-01-31 | 4D Pharma Res Ltd | COMPOSITIONS INCLUDING BACTERIAL STRAINS |
MA41010B1 (en) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
DK3209310T3 (en) | 2015-11-20 | 2018-04-16 | 4D Pharma Res Ltd | COMPOSITIONS COMPREHENSIVE BAKERY STUES |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
AU2017226831B2 (en) | 2016-03-04 | 2018-10-04 | 4D Pharma Plc | Compositions comprising bacterial Blautia strains for treating visceral hypersensitivity |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
TWI782800B (en) * | 2016-06-15 | 2022-11-01 | 英商4D製藥研究有限公司 | Composition comprising a bacterial strain and its use, process of producing and product |
TWI621708B (en) * | 2016-06-15 | 2018-04-21 | 4D製藥研究有限公司 | Immune modulation |
TWI750342B (en) * | 2016-06-15 | 2021-12-21 | 英商4D製藥研究有限公司 | Composition comprising a bacterial strain and its use, process of producing and product |
TW201821093A (en) | 2016-07-13 | 2018-06-16 | 英商4D製藥有限公司 | Compositions comprising bacterial strains |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
PT3630136T (en) | 2017-05-22 | 2021-06-11 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
EP3630942B1 (en) | 2017-05-24 | 2022-11-30 | 4D Pharma Research Limited | Compositions comprising bacterial strain |
EP3638271B1 (en) | 2017-06-14 | 2020-10-14 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
BR112019026677A2 (en) | 2017-06-14 | 2020-06-30 | 4D Pharma Research Limited | compositions comprising bacterial strains |
CN111961616B (en) * | 2020-08-13 | 2022-04-26 | 浙江工商大学 | Bacteroides thetaiotaomicron and uses thereof |
CN112056562B (en) * | 2020-08-13 | 2022-03-04 | 浙江工商大学 | Bacteroides thetaiotaomicron and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0127916D0 (en) * | 2001-11-21 | 2002-01-16 | Rowett Res Inst | Method |
EP2211879B1 (en) * | 2007-10-26 | 2014-05-07 | Brenda E. Moore | Probiotic compositions and methods for inducing and supporting weight loss |
WO2011153226A2 (en) * | 2010-06-01 | 2011-12-08 | Moore Research Enterprises Llc | Cellular constituents from bacteroides, compositions thereof, and therapeutic methods employing bacteroides or cellular constituents thereof |
CN103652322B (en) * | 2012-09-21 | 2016-02-10 | 临沂思科生物科技有限公司 | A kind of preparation method of lactobacteria-containing composite probiotics feed additive |
CN103750341A (en) * | 2014-01-13 | 2014-04-30 | 苏州万生源生物科技有限公司 | Inactivated bacteroid micro-ecological preparation and preparation method thereof |
-
2014
- 2014-09-30 CN CN201410522420.6A patent/CN104546935A/en active Pending
-
2015
- 2015-10-15 HK HK15110140.1A patent/HK1209348A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN104546935A (en) | 2015-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1209348A1 (en) | Use of bacteroides thetaiotaomicron in the treatment or prevention of rheumatoid arthritis or related diseases | |
HK1209347A1 (en) | Use of bacteroides dorei in the treatment or prevention of rheumatoid arthritis or related diseases | |
HK1209365A1 (en) | Use of bacteroides plebeius in the treatment or prevention of rheumatoid arthritis or related diseases | |
HK1209360A1 (en) | Use of bacteroides ovatus in the treatment or prevention of rheumatoid arthritis or related diseases | |
HK1209350A1 (en) | Use of bacteroides caccae in the treatment or prevention of rheumatoid arthritis or related diseases | |
IL283086A (en) | Use of cannabidiol in the treatment of tuberous sclerosis complex | |
HK1209349A1 (en) | Use of parabacteroides merdae in the treatment or prevention of rheumatoid arthritis or related diseases | |
GB201411496D0 (en) | Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy | |
PL3277280T3 (en) | Isomyosmine for use in the treatment of autoimmune diseases | |
IL251904B (en) | Apilimod for use in the treatment of melanoma | |
HK1209346A1 (en) | Use of bifidobacterium bifidum in the treatment or prevention of rheumatoid arthritis or related diseases | |
EP3202892A4 (en) | Uses of bacteroides in treatment or prevention of obesity-related diseases | |
HK1256164A1 (en) | Agents for use in the treatment of glioma | |
PL3160464T3 (en) | 6-hydroxybuspirone for use in the treatment of movement disorders | |
HK1209351A1 (en) | Use of haemophilus parainfluenzae in the treatment or prevention of rheumatoid arthritis or related diseases | |
HK1209359A1 (en) | Use of megamonas hypermegale in the treatment or prevention of rheumatoid arthritis or related diseases | |
EP3202891A4 (en) | Uses of bacteroides in treatment or prevention of obesity-related diseases | |
HK1209363A1 (en) | Use of lactobacillus crispatus in the treatment or prevention of rheumatoid arthritis or related diseases | |
HK1209366A1 (en) | Use of lactococcus lactis in the treatment or prevention of rheumatoid arthritis or related diseases | |
EP2937127C0 (en) | Device for the treatment of precipitation water | |
HK1209357A1 (en) | Use of dialister invisus in the treatment or prevention of rheumatoid arthritis or related diseases | |
IL252493B (en) | Compounds for use in the prevention or treatment of cancer | |
IL251135A (en) | Method for the synthesis of hydroxy-triglycerides and use thereof for the prevention and treatment of diseases | |
HK1209369A1 (en) | Use of alistipes shahii in the treatment or prevention of rheumatoid arthritis or related diseases | |
HK1209367A1 (en) | Use of clostridium nexile in the treatment or prevention of rheumatoid arthritis or related diseases |